Compounds/Other Therapeutic Agents and Methods

Title Reference Number A Compound for the Maintenance of Prostate Health and the Treatment of Prostatic Disorders STC-LS-0357 A Method of Conforming Predefined Photon Beams to a Tumor Volume STC-PS-0810 An Attenuated E.Coli Vaccine For Enterotoxigenic E. Coli (ETEC) STC-LS-0422 Artificial Diatom Feed Supplements: Controlled Release for Commercial Insecticide Applications STC-PS-0913 Bead-based Detection of Glutathione and GST-fusion Protein Multiplexing Using High Site Density Glutathione Beads STC-LS-0323 Chemoattractant Receptor Transfected U937 Cells STC-LS-0361 Compound for Treatment of TB with Improved Activity over Isoniazid STC-LS-0378 Compounds and Methods for Protection Against Dialysis-Induced Inflammation and Inflammatory Stress STC-LS-0437 Curcuminoid Analogs in Prostate Cancer Prevention and Progression STC-LS-0423 Delivery of Passive Immunity to Animals of Mariculture STC-LS-0350 Deoxygossylic Compounds STC-LS-0095 Exercise Hydration Regimen to Enhance Exercise Endurance and Performance STC-LS-0085 Extended Viability Vaccines for TB STC-LS-0401 Heat Shock Response and Virus Replication STC-LS-0208 Hydroxynapthoic Acids and Derivatives STC-LS-0120 Identification of compounds specific for binding to Estrogen Receptor alpha and beta and G protein Receptor 30 (GPR30) STC-LS-0307 Immunoassay Detection of Anthrax Infection STC-LS-0270 Lead Compounds and Method for Discovering Lead Compounds for the Inhibition of Anti-Apoptotic Bcl-2 Family of Proteins STC-LS-0377 Maui Scheduler - Version 2.0 STC-PS-0539 Method of Preventing or Reducing the Likelihood of Pregnancy STC-LS-0267 Methods for Immune Suppression Using Heat Shock Proteins STC-LS-0136A Multifunctional Nanoparticles for Enhanced Drug Delivery to the Lung STC-LS-0392 Non-embryonic Human Renal Stem Cells STC-LS-0321 Novel Cell-Penetrating Peptide for Targeted and Specific Cellular and Subcellular Delivery STC-LS-0429 Novel Hybrid Peptide for Imaging and Treatment of Melanoma STC-LS-0432 Peptide and Small Molecule Inhibitors of the Interaction of ICAM-1 with LFA-1. Treatments for Leukemia, psoriasis, transplant rejection and inflammatory diseases such as ischemia-reperfusion injury, stroke, septic shock and rheumatoid arthritis. STC-LS-0165 Polyclonal Antibodies STC-LS-0379 Polyclonal Antibodies Raised Against Full Length Human Syndecan-1 STC-LS-0376 Porous Microspheres that Incorporate Functional Biological Components STC-PS-0619 Post Sun Exposure Prophylaxis Of Melanoma STC-LS-0352 Protein Disulfide Isomerase Inhibitors for Inhibiting HIV Entry Into Cells STC-LS-0112 Recombinant Human Aprotinin for Reduced Bleeding, Risk of Stroke, and Need for Blood Transfusions during Cardiopulmonary Bypass Surgery STC-LS-0271 Repurposing Agents for the Prevention and Treatment of Cancer STC-LS-0395 RTO Murine Monoclonal Antibody to Human Platelet Factor Four STC-LS-0343 Small Molecule Inhibitors of Glutathione S-Transferase P1-1 for Treating Cancer STC-LS-0265 Small Molecule Inhibitors of Pancreatic Cholesterol Esterase for the Prevention of Cholesterol Absorption STC-LS-0119 Small Molecule that Inhibits ABCB1 Activity STC-LS-0354 Smart Drugs STC-PS-0924 Substituted trans-Stilbenes, Including Analogs of the Natural Product Resveratrol, Inhibit the TNFa-induced Activation of Transcription Factor NF-kB STC-LS-0345 Uses of Chlorine Ion Uptake Inhibitors for Treatment of Neurological Disorders and Prophylaxis STC-LS-0447 Vaccine to Reduce or Inhibit Carriage and Shedding of Enterohemorrihagic E. Coli in Cattle STC-LS-0368 Y Shaped Neurostimulation Lead and New Method for Tonneling such a Lead for Peripheral Neurostimulation STC-LS-0430

There are 42 technologies in this category.